NEW YORK, June 7, 2023 /PRNewswire/ — The Gross Law Firm issues the following notice to shareholders of Reata Pharmaceuticals, Inc.: On May 10, 2023, Reata issued a press release announcing its financial results for the first quarter of 2023. Among other items, Reata announced its decision to discontinue studies…Read More
INVESTIGATION ALERT The Gross Law Firm Notifies Shareholders of Reata Pharmaceuticals Inc of an Investigation and Potential Class Action Lawsuit NASDAQ RETA MarketScreener
